The CBO estimates about the number of people who will use the public option could be very wrong. Of course that could depend on the risk adjustment mechanism in the exchange. That is a very real concerns, Ezra Klein worried by some things which aren’t.

Jane revisits the issues with Eshoo’s biosimilars amendment. The UAEM and AMSA respond to Eshoo defense of her amendment even though Waxman said her amendment has a real “evergreening problem.”

Sherrod Brown is trying to improve how reform deals with biosimilars. He worries the evergreening  problem would led to an “endless monopoly period.”

Roland Burris is still claiming he will stand strong for the public option.

With the vote on the House bill expect soon House Progressives are pushing for improvements. One of these changes would be a better rating ceiling for the Public Option.

CBS does nothing while Lieberman tells lies on Face The Nation. Even though Lieberman has been trying to kill the public option, if it fails it would still ultimately be Harry Reid’s fault.